DOI: 10.12890/2020_001718

Stress Cardiomyopathy in COVID-19 Disease

Authors

  • Maria Cristina Pasqualetto ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy
  • Eleonora Secco ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy
  • Manuele Nizzetto ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy
  • Moreno Scevola ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy
  • Lorella Altafini ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy
  • Alberto Cester ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy
  • Fausto Rigo ULSS 3 Serenissima (COVID-19 Hospital), Dolo, Italy

mariacri.pasqualetto@aulss3.veneto.it

Keywords

COVID-19, Takotsubo syndrome, cardiomyopathy

Abstract

Patients affected by COVID-19 pneumonia may develop stress cardiomyopathy, also known as Takotsubo syndrome (TTS), at different stages during the disease and with different degrees of left ventricular dysfunction. We describe three cases of TTS in COVID-19-positive patients with different clinical presentations and outcomes. One of them died, while in the other two coronary angiography confirmed the diagnosis but was postponed until after pneumonia resolution because of the risk of virus spread.

View the entire article

Downloads

Published

2020-05-15

Issue

Vol. 7 No. 6 (2020)

Categories

How to Cite

1.
Pasqualetto MC, Secco E, Nizzetto M, Scevola M, Altafini L, Cester A, et al. Stress Cardiomyopathy in COVID-19 Disease. EJCRIM [Internet]. 2020 May 15 [cited 2026 Nov. 3];7(6). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1718

Most read articles by the same author(s)